The newly approved drug, which treats potentially fatal pulmonary arterial hypertension, is estimated to ring up as much as $7.5 billion in yearly sales.
Beer Store continues steady flow of closures in Ontario | Globalnews.ca
September 16, 2025
10:19 am
